India’s Most Expensive Stock Posts Stellar Q2: 150 Per Cent Revenue Jump, 179 Per Cent Profit Surge! Trading Below Book Value
India’s Most Expensive Stock Posts Stellar Q2: 150 Per Cent Revenue Jump, 179 Per Cent Profit Surge! Trading Below Book Value

India’s Most Expensive Stock Posts Stellar Q2: 150 Per Cent Revenue Jump, 179 Per Cent Profit Surge! Trading Below Book Value

This stock is more expensive than MRF. How a Single-Digit Share Value Soared to Six Figures in 4 Months!

Abhishek Wani Article rating: 5.0

This stock is more expensive than MRF. How a Single-Digit Share Value Soared to Six Figures in 4 Months!

Mukul Agrawal portfolio company announces robust results: Net profits skyrocket by 2,600 per cent, stock gains 200 per cent in just one year!
Mukul Agrawal portfolio company announces robust results: Net profits skyrocket by 2,600 per cent, stock gains 200 per cent in just one year!

Mukul Agrawal portfolio company announces robust results: Net profits skyrocket by 2,600 per cent, stock gains 200 per cent in just one year!

The company's shares have delivered a multibagger return of around 350 per cent to their shareholders in the past three years.

Rakesh Deshmukh Article rating: 3.6

In Q4, FIIs increased their stake, while ace investor Mukul Agrawal has consistently held a 1.06 per cent stake for the past eight quarters.

Explosive growth alert: Smallcap pharma rockets 10 per cent hits record 52 week high on stellar quarterly performance
Explosive growth alert: Smallcap pharma rockets 10 per cent hits record 52 week high on stellar quarterly performance

Explosive growth alert: Smallcap pharma rockets 10 per cent hits record 52 week high on stellar quarterly performance

Over the past six months the company's shares have generated a stellar return of 75.54 per cent while during the same time frame BSE Healthcare has risen by 23.86 per cent

Kamal Mansuriya Article rating: 4.4

Over the past six months the company's shares have generated a stellar return of 75.54 per cent while during the same time frame BSE Healthcare has risen by 23.86 per cent

Rs 1,108 crore order book: Investors pile into multibagger explosives stock as the company reports a 540 per cent jump in net profit!
Rs 1,108 crore order book: Investors pile into multibagger explosives stock as the company reports a 540 per cent jump in net profit!

Rs 1,108 crore order book: Investors pile into multibagger explosives stock as the company reports a 540 per cent jump in net profit!

The stock gave multibagger returns of 113 per cent returns in just 1 month, up 340 per cent in 3 years and over 1,400 per cent returns in 1 decade.

Kiran Shroff Article rating: 4.0

Additionally, the company’s order book stands at Rs 1,108 crore which is 5.50 times of FY23 revenue. Out of the total order book, 87 per cent of orders are domestic orders and 13 per cent are export orders. Order Inflow in YTD FY24 stands at Rs 725 crore. These include orders from BDL, L&T and MoD (IAF) to be executed over the next 12-24 months. working towards securing more orders in defence and explosive segments.

DSIJ MINDSHARE

Mkt Commentary21-Nov, 2024

Mindshare21-Nov, 2024

Mindshare21-Nov, 2024

Mindshare21-Nov, 2024

Multibaggers21-Nov, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR